<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antimicrob Agents Chemother</journal-id><journal-id journal-id-type="iso-abbrev">Antimicrob. Agents Chemother</journal-id><journal-id journal-id-type="hwp">aac</journal-id><journal-id journal-id-type="pmc">aac</journal-id><journal-id journal-id-type="publisher-id">AAC</journal-id><journal-title-group><journal-title>Antimicrobial Agents and Chemotherapy</journal-title></journal-title-group><issn pub-type="ppub">0066-4804</issn><issn pub-type="epub">1098-6596</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5913926</article-id><article-id pub-id-type="pmid">29358287</article-id><article-id pub-id-type="publisher-id">01533-17</article-id><article-id pub-id-type="doi">10.1128/AAC.01533-17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Biologic Response Modifiers</subject></subj-group></article-categories><title-group><article-title>Using Yeast Synthetic Lethality To Inform Drug Combination for Malaria</article-title><alt-title alt-title-type="running-head">Learning from Yeast for Combinatorial Chemotherapy</alt-title><alt-title alt-title-type="short-authors">Subramaniam et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Subramaniam</surname><given-names>Suvitha</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schmid</surname><given-names>Christoph D.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Guan</surname><given-names>Xue Li</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>M&#x000e4;ser</surname><given-names>Pascal</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><aff id="aff1"><label>a</label>Swiss Tropical and Public Health Institute, Basel, Switzerland</aff><aff id="aff2"><label>b</label>University of Basel, Basel, Switzerland</aff><aff id="aff3"><label>c</label>Swiss Institute of Bioinformatics, Basel, Switzerland</aff><aff id="aff4"><label>d</label>Nanyang Technological University, Singapore</aff></contrib-group><author-notes><corresp id="cor1">Address correspondence to Pascal M&#x000e4;ser, <email>pascal.maeser@swisstph.ch</email>.</corresp><fn fn-type="other"><p><bold>Citation</bold> Subramaniam S, Schmid CD, Guan XL, M&#x000e4;ser P. 2018. Using yeast synthetic lethality to inform drug combination for malaria. Antimicrob Agents Chemother 62:e01533-17. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.01533-17">https://doi.org/10.1128/AAC.01533-17</ext-link>.</p></fn></author-notes><pub-date pub-type="epreprint"><day>22</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>27</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>3</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>62</volume><issue>4</issue><elocation-id>e01533-17</elocation-id><history><date date-type="received"><day>26</day><month>7</month><year>2017</year></date><date date-type="rev-request"><day>29</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>30</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Subramaniam et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Subramaniam et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="zac004187003001.pdf"/><abstract><title>ABSTRACT</title><p>Combinatorial chemotherapy is necessary for the treatment of malaria. However, finding a suitable partner drug for a new candidate is challenging. Here we develop an algorithm that identifies all of the gene pairs of <named-content content-type="genus-species">Plasmodium falciparum</named-content> that possess orthologues in yeast that have a synthetic lethal interaction but are absent in humans. This suggests new options for drug combinations, particularly for inhibitors of targets such as <named-content content-type="genus-species">P. falciparum</named-content> calcineurin, cation ATPase 4, or phosphatidylinositol 4-kinase.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>antimalarials</kwd><kwd>combinatorial chemotherapy</kwd><kwd>gene orthology</kwd><kwd>synthetic lethality</kwd><kwd>yeast genetics</kwd></kwd-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="33"/><page-count count="5"/><word-count count="3484"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>TEXT</title><p>There is a persistent need for new antimalarials due to the evolution of drug-resistant parasites. Under the auspices of the Medicines for Malaria Venture (MMV), new drug candidates that are active against artemisinin-resistant isolates of <named-content content-type="genus-species">Plasmodium falciparum</named-content> are being developed; the frontrunners are artefenomel, KAF156, cipargamin, DSM265, MMV390048, ferroquine, and tafenoquine (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). However, the choice of the right partner drug will be critical for the success of these new molecules, as the WHO enforces the application of antimalarials in combination therapy (<xref rid="B3" ref-type="bibr">3</xref>). In addition to protecting each other from drug resistance, two molecules to be combined need to be compatible for coformulation, should have matching pharmacokinetic profiles, and must not have unfavorable polypharmacology (<xref rid="B4" ref-type="bibr">4</xref><xref ref-type="bibr" rid="B5">&#x02013;</xref><xref rid="B6" ref-type="bibr">6</xref>). Ideally, the two molecules would potentiate each other, thereby decreasing the duration of treatment and the required doses. Thus, combinatorial chemotherapy not only can reduce the risk of drug resistance but also can enhance drug safety and drug efficacy, enabling the ambitious goal of a &#x0201c;single-exposure radical cure&#x0201d; (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>).</p><p>Here we propose to support the matchmaking of antimalarial candidates by learning from yeast reverse genetics. <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> is probably the best studied of all eukaryotes. Only about 20% of its protein-coding genes are essential for growth on rich medium (<xref rid="B9" ref-type="bibr">9</xref>). High-throughput crossing experiments have shown that many viable <named-content content-type="genus-species">S. cerevisiae</named-content> gene deletion mutants possess synthetic phenotypes, i.e., growth defects that become apparent only in the absence of another nonessential gene. The concept of genetic synthetic lethality can be adopted to combination chemotherapy (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B10" ref-type="bibr">10</xref><xref ref-type="bibr" rid="B11">&#x02013;</xref><xref rid="B12" ref-type="bibr">12</xref>). The principal idea is to extrapolate from synthetic lethal gene pairs in <named-content content-type="genus-species">S. cerevisiae</named-content> to orthologous pairs of genes in <named-content content-type="genus-species">P. falciparum</named-content>, assuming that the combined inhibition of the respective gene products will produce a synergistic effect. However, this seemingly straightforward approach is complicated by the fact that <named-content content-type="genus-species">S. cerevisiae</named-content> is more closely related to <named-content content-type="genus-species">Homo sapiens</named-content> than to <named-content content-type="genus-species">P. falciparum</named-content> (<xref rid="B13" ref-type="bibr">13</xref>). Thus, a drug combination inferred from yeast synthetic genetic lethality might enhance the toxicity to humans rather than enhancing the antimalarial efficacy. To avoid such a scenario, we developed an algorithm to exclude gene pairs that are conserved in <named-content content-type="genus-species">H. sapiens</named-content>.</p><p>Yeast synthetic lethal gene pairs were obtained from BioGRID 3.4 (<xref rid="B14" ref-type="bibr">14</xref>) and pairs and groups of orthologous genes from the OrthoMCL 5 database, based on the similarity of the derived protein sequences (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>). Mining the OrthoMCL database with the 16,217 synthetic lethal gene pairs of <named-content content-type="genus-species">S. cerevisiae</named-content> identified in BioGRID, we found that only 1,505 pairs (9.3%) had direct orthologues in <named-content content-type="genus-species">P. falciparum</named-content> for both gene products (<xref ref-type="fig" rid="F1">Fig. 1</xref>). From this set, we tested all of the proteins for the presence of an orthologue in the human proteome, again referring to the downloaded OrthoMCL database. This assessment included direct pairwise orthology between the <named-content content-type="genus-species">P. falciparum</named-content> or <named-content content-type="genus-species">S. cerevisiae</named-content> protein and a <named-content content-type="genus-species">H. sapiens</named-content> protein or indirect orthology in which either the malaria protein or its yeast orthologue belonged to an OrthoMCL group that also contained a human protein (<xref ref-type="fig" rid="F1">Fig. 1</xref>). All of the <named-content content-type="genus-species">P. falciparum</named-content> gene pairs for which both gene products tested positive for direct or indirect human orthology were eliminated. This process yielded 37 pairs composed of 55 unique <named-content content-type="genus-species">P. falciparum</named-content> proteins that fulfilled the conditions that (i) their direct orthologues in <named-content content-type="genus-species">S. cerevisiae</named-content> exhibit synthetic lethality and (ii) at least one of the two proteins has neither a direct nor an indirect orthologue in the human proteome. Therefore, we suggest these pairs as targets for combinatorial chemotherapy. The comparative genomics pipeline (<xref ref-type="fig" rid="F1">Fig. 1</xref>) is built with self-developed Python scripts that are available for download at the GitHub repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/suvi-subra/SynthLeth">https://github.com/suvi-subra/SynthLeth</ext-link>).</p><fig id="F1" orientation="portrait" position="float"><label>FIG 1</label><caption><p>Graphic representation of the algorithm, with the numbers of <named-content content-type="genus-species">P. falciparum</named-content> gene pairs that passed the filters; the final 37 are shown in <xref ref-type="table" rid="T1">Table 1</xref>. Yellow, <named-content content-type="genus-species">S. cerevisiae</named-content>; blue, <named-content content-type="genus-species">P. falciparum</named-content>; red, <named-content content-type="genus-species">H. sapiens</named-content>.</p></caption><graphic xlink:href="zac0041870030001"/></fig><p>The final set of 37 pairs was enriched in druggable proteins (<xref ref-type="table" rid="T1">Table 1</xref>). Of the 55 proteins in the set, 30 either had been validated as drug targets or had a positive &#x0201c;druggability index,&#x0201d; as predicted by TDR Targets (<xref rid="B17" ref-type="bibr">17</xref>). Some of the suggested combinations affected the same pathway, e.g., the pyridoxal kinase-like protein and pyridoxine biosynthesis protein involved in vitamin B<sub>6</sub> metabolism or NAD(P)H-dependent glutamate synthase and NADP-specific glutamate dehydrogenase; the latter is selectively inhibited by isophthalic acid (<xref rid="B18" ref-type="bibr">18</xref>), while glutamate synthase had been suggested as a target based on comparative genomics (<xref rid="B19" ref-type="bibr">19</xref>). Calcineurin subunit B paired with the <named-content content-type="genus-species">P. falciparum</named-content> cation/H<sup>+</sup> antiporter (PfCHA), which is sensitive to known inhibitors such as KB-R7943 (<xref rid="B20" ref-type="bibr">20</xref>). Hubs of inferred interactions were <named-content content-type="genus-species">P. falciparum</named-content> apurinic/apyrimidinic endonuclease 1 (PfAPN1) and the <named-content content-type="genus-species">P. falciparum</named-content> U5 small nuclear ribonucleoprotein (PfSNU114) of the spliceosome, both of which are involved in the processing of nucleic acids. Two proteins in the target set were of particular pharmacological interest, namely, <named-content content-type="genus-species">P. falciparum</named-content> Ca<sup>2+</sup>-ATPase 4 (PfATP4) and <named-content content-type="genus-species">P. falciparum</named-content> phosphatidylinositol 4-kinase (PfPI4K). Either protein is targeted by new antimalarial candidates (<xref rid="B21" ref-type="bibr">21</xref><xref ref-type="bibr" rid="B22">&#x02013;</xref><xref rid="B27" ref-type="bibr">27</xref>). PfATP4 is the target of cipargamin and paired with PfCHA (<xref ref-type="table" rid="T1">Table 1</xref>), suggesting testing for potential synergy between cipargamin and KB-R7943. PfPI4K, the target of imidazolopiperazines and MMV390048, paired with ubiquitin-conjugating enzyme E2 (<xref ref-type="table" rid="T1">Table 1</xref>). An inhibitor of Atg8-Atg3 interactions was identified from the MMV Malaria Box (<xref rid="B28" ref-type="bibr">28</xref>), and ubiquitin-protein ligase E3 was proposed as an antimalarial target (<xref rid="B29" ref-type="bibr">29</xref>). The inferred link between phosphatidylinositol 4-kinase and ubiquitination suggests testing for potential synergy between PfPI4K inhibitors and <named-content content-type="genus-species">P. falciparum</named-content> proteasome inhibitors (<xref rid="B30" ref-type="bibr">30</xref><xref ref-type="bibr" rid="B31">&#x02013;</xref><xref rid="B32" ref-type="bibr">32</xref>).</p><table-wrap id="T1" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Pairs of <named-content content-type="genus-species">P. falciparum</named-content> proteins suggested as targets for combinatorial chemotherapy, based on synthetic lethal genetic interactions in <named-content content-type="genus-species">S. cerevisiae</named-content></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr valign="bottom"><th align="left" rowspan="1" colspan="1">Gene 1 identification</th><th align="left" rowspan="1" colspan="1">Gene 1 product<xref ref-type="table-fn" rid="T1F1"><sup><italic>a</italic></sup></xref></th><th align="left" rowspan="1" colspan="1">Gene 2 identification</th><th align="left" rowspan="1" colspan="1">Gene 2 product</th></tr></thead><tbody><tr valign="top"><td rowspan="1" colspan="1">PF14_0492</td><td rowspan="1" colspan="1">Calcineurin subunit B</td><td rowspan="1" colspan="1">PFF0170w</td><td rowspan="1" colspan="1">Cation/H+ antiporter</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFL0590c</td><td rowspan="1" colspan="1">Non-SERCA-type Ca<sup>2+</sup>-transporting P-ATPase 4</td><td rowspan="1" colspan="1">PFF0170w</td><td rowspan="1" colspan="1">Cation/H+ antiporter</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFE0485w</td><td rowspan="1" colspan="1">Phosphatidylinositol 4-kinase</td><td rowspan="1" colspan="1">PFF0305c</td><td rowspan="1" colspan="1">Ubiquitin-conjugating enzyme E2</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF08_0031</td><td rowspan="1" colspan="1">Dicarboxylate/tricarboxylate carrier</td><td rowspan="1" colspan="1">mal_mito_2</td><td rowspan="1" colspan="1">Cytochrome <italic>c</italic> oxidase subunit 1</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFF1105c</td><td rowspan="1" colspan="1">Chorismate synthase</td><td rowspan="1" colspan="1">PF14_0511</td><td rowspan="1" colspan="1">Glucose-6-phosphate dehydrogenase</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFL2465c</td><td rowspan="1" colspan="1">Thymidylate kinase</td><td rowspan="1" colspan="1">PF13_0176</td><td rowspan="1" colspan="1">Apurinic/apyrimidinic endonuclease</td></tr><tr valign="top"><td rowspan="1" colspan="1">MAL13P1.346</td><td rowspan="1" colspan="1">DNA repair endonuclease</td><td rowspan="1" colspan="1">PF13_0176</td><td rowspan="1" colspan="1">Apurinic/apyrimidinic endonuclease</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFB0160w</td><td rowspan="1" colspan="1">ERCC1 nucleotide excision repair protein</td><td rowspan="1" colspan="1">PF13_0176</td><td rowspan="1" colspan="1">Apurinic/apyrimidinic endonuclease</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFF0715c</td><td rowspan="1" colspan="1">Endonuclease III homologue</td><td rowspan="1" colspan="1">PF13_0176</td><td rowspan="1" colspan="1">Apurinic/apyrimidinic endonuclease</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFD0865c</td><td rowspan="1" colspan="1">Cdc2-related protein kinase 1</td><td rowspan="1" colspan="1">PFF0165c</td><td rowspan="1" colspan="1">Conserved <named-content content-type="genus-species">Plasmodium</named-content> protein, unknown function</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFL1635w</td><td rowspan="1" colspan="1">Sentrin-specific protease 1</td><td rowspan="1" colspan="1">PF10_0092</td><td rowspan="1" colspan="1">Metallopeptidase</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF13_0251</td><td rowspan="1" colspan="1">DNA topoisomerase 3</td><td rowspan="1" colspan="1">PF10_0092</td><td rowspan="1" colspan="1">Metallopeptidase</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFF0775w</td><td rowspan="1" colspan="1">Pyridoxal kinase-like protein</td><td rowspan="1" colspan="1">PFF1025c</td><td rowspan="1" colspan="1">Pyridoxine biosynthesis protein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF11_0192</td><td rowspan="1" colspan="1">Histone acetyltransferase</td><td rowspan="1" colspan="1">PFF1180w</td><td rowspan="1" colspan="1">Anaphase-promoting complex subunit</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFL2440w</td><td rowspan="1" colspan="1">DNA repair protein</td><td rowspan="1" colspan="1">MAL7P1.94</td><td rowspan="1" colspan="1">Prefoldin subunit 3</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF11_0087</td><td rowspan="1" colspan="1">DNA repair protein</td><td rowspan="1" colspan="1">PF10_0041</td><td rowspan="1" colspan="1">U5 small nuclear ribonucleoprotein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFB0445c</td><td rowspan="1" colspan="1">ATP-dependent RNA helicase</td><td rowspan="1" colspan="1">PF10_0041</td><td rowspan="1" colspan="1">U5 small nuclear ribonucleoprotein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFE0925c</td><td rowspan="1" colspan="1">ATP-dependent RNA helicase</td><td rowspan="1" colspan="1">PF10_0041</td><td rowspan="1" colspan="1">U5 small nuclear ribonucleoprotein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF10_0294</td><td rowspan="1" colspan="1">Pre-mRNA-splicing factor ATP-dependent RNA helicase</td><td rowspan="1" colspan="1">PF10_0041</td><td rowspan="1" colspan="1">U5 small nuclear ribonucleoprotein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFC1060c</td><td rowspan="1" colspan="1">U4/U6.U5 tri-small-nuclear-ribonucleoprotein-associated protein 1</td><td rowspan="1" colspan="1">PF10_0041</td><td rowspan="1" colspan="1">U5 small nuclear ribonucleoprotein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF13_0096</td><td rowspan="1" colspan="1">U4/U6.U5 tri-small-nuclear-ribonucleoprotein-associated protein 2</td><td rowspan="1" colspan="1">PF10_0041</td><td rowspan="1" colspan="1">U5 small nuclear ribonucleoprotein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFC0365w</td><td rowspan="1" colspan="1">Pre-mRNA-processing factor 19</td><td rowspan="1" colspan="1">PF10_0041</td><td rowspan="1" colspan="1">U5 small nuclear ribonucleoprotein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFD0685c</td><td rowspan="1" colspan="1">Structural maintenance of chromosomes protein 3</td><td rowspan="1" colspan="1">PF10_0041</td><td rowspan="1" colspan="1">U5 small nuclear ribonucleoprotein</td></tr><tr valign="top"><td rowspan="1" colspan="1">MAL13P1.214</td><td rowspan="1" colspan="1">Phosphoethanolamine <italic>N</italic>-methyltransferase</td><td rowspan="1" colspan="1">PFA0455c</td><td rowspan="1" colspan="1">Fatty acid elongation protein, GNS1/SUR4 family</td></tr><tr valign="top"><td rowspan="1" colspan="1">MAL13P1.214</td><td rowspan="1" colspan="1">Phosphoethanolamine <italic>N</italic>-methyltransferase</td><td rowspan="1" colspan="1">PFL0950c</td><td rowspan="1" colspan="1">Aminophospholipid-transporting P-ATPase</td></tr><tr valign="top"><td rowspan="1" colspan="1">MAL8P1.17</td><td rowspan="1" colspan="1">Protein disulfide isomerase</td><td rowspan="1" colspan="1">PF10_0092</td><td rowspan="1" colspan="1">Metallopeptidase</td></tr><tr valign="top"><td rowspan="1" colspan="1">MAL8P1.17</td><td rowspan="1" colspan="1">Protein disulfide isomerase</td><td rowspan="1" colspan="1">PFB0920w</td><td rowspan="1" colspan="1">DnaJ protein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF07_0029</td><td rowspan="1" colspan="1">Heat shock protein 86</td><td rowspan="1" colspan="1">MAL13P1.139</td><td rowspan="1" colspan="1">Mitochondrial fission 1 protein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF07_0029</td><td rowspan="1" colspan="1">Heat shock protein 86</td><td rowspan="1" colspan="1">PFI0300w</td><td rowspan="1" colspan="1">Vacuolar protein sorting-associated protein 46</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF14_0068</td><td rowspan="1" colspan="1">rRNA 2&#x02032;-<italic>O</italic>-methyltransferase fibrillarin</td><td rowspan="1" colspan="1">PFF1180w</td><td rowspan="1" colspan="1">Anaphase-promoting complex subunit</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF14_0261</td><td rowspan="1" colspan="1">Proliferation-associated protein 2g4</td><td rowspan="1" colspan="1">PF14_0612</td><td rowspan="1" colspan="1">Zinc finger protein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF14_0286</td><td rowspan="1" colspan="1">NADP-specific glutamate dehydrogenase</td><td rowspan="1" colspan="1">PF14_0334</td><td rowspan="1" colspan="1">NAD(P)H-dependent glutamate synthase</td></tr><tr valign="top"><td rowspan="1" colspan="1">PF14_0401</td><td rowspan="1" colspan="1">tRNA import protein</td><td rowspan="1" colspan="1">PF13_0257</td><td rowspan="1" colspan="1">Glutamate-tRNA ligase</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFC0510w</td><td rowspan="1" colspan="1">E3 ubiquitin-protein ligase</td><td rowspan="1" colspan="1">PFI0300w</td><td rowspan="1" colspan="1">Vacuolar protein sorting-associated protein 46</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFE0750c</td><td rowspan="1" colspan="1">Pre-mRNA-splicing factor</td><td rowspan="1" colspan="1">PF14_0688</td><td rowspan="1" colspan="1">Pre-mRNA-splicing factor ISY1</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFF1385c</td><td rowspan="1" colspan="1">Conserved <named-content content-type="genus-species">Plasmodium</named-content> protein</td><td rowspan="1" colspan="1">PFB0920w</td><td rowspan="1" colspan="1">DnaJ protein</td></tr><tr valign="top"><td rowspan="1" colspan="1">PFL1140w</td><td rowspan="1" colspan="1">Vacuolar iron transporter</td><td rowspan="1" colspan="1">PFL0725w</td><td rowspan="1" colspan="1">Thioredoxin peroxidase 2</td></tr></tbody></table><table-wrap-foot><fn fn-type="abbr" id="T1F1"><label>a</label><p>SERCA, sarcoendoplasmic reticulum calcium transport ATPase; ERCC1, excision repair cross-complementation group 1.</p></fn></table-wrap-foot></table-wrap><p>The present approach critically depends on the existence of <named-content content-type="genus-species">S. cerevisiae</named-content> genes that (i) possess synthetic lethal phenotypes and (ii) are orthologous to known <named-content content-type="genus-species">P. falciparum</named-content> drug target genes. This seems contradictory; by definition, drug targets are essential and genes with synthetic phenotypes are nonessential. However, we show here that several validated drug targets of <named-content content-type="genus-species">P. falciparum</named-content> possess orthologues in <named-content content-type="genus-species">S. cerevisiae</named-content> that are nonessential (<xref ref-type="table" rid="T1">Table 1</xref>). Phosphoethanolamine methyltransferase and phosphatidylinositol 4-kinase (<xref ref-type="table" rid="T1">Table 1</xref>), for instance, have been demonstrated to be essential enzymes in <named-content content-type="genus-species">P. falciparum</named-content> (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Most of the genes that are conserved between <named-content content-type="genus-species">S. cerevisiae</named-content> and <named-content content-type="genus-species">P. falciparum</named-content> also have an orthologue in <named-content content-type="genus-species">H. sapiens</named-content> (the OrthoMCL database contains only 80 yeast genes with an orthologue in <named-content content-type="genus-species">P. falciparum</named-content> but not in <named-content content-type="genus-species">H. sapiens</named-content>). We speculate that, of the conserved genes that are essential in yeast, many may also be essential in <named-content content-type="genus-species">H. sapiens</named-content> and their products not suitable as drug targets. On the other hand, conserved genes that are devoid of synthetic phenotypes in yeast might also be disposable in <named-content content-type="genus-species">P. falciparum</named-content> and thus not suitable either. The conserved genes that have synthetic lethal phenotypes in yeast might be the most interesting pharmacologically.</p><p>The proposed algorithm strongly narrows the target space for antimalarial drug combinations by including potentially synergistic interactions involving efficacy against <named-content content-type="genus-species">P. falciparum</named-content> as well as toxicity against <named-content content-type="genus-species">H. sapiens</named-content>. The fact that it relies on genome-scale experimental data from <named-content content-type="genus-species">S. cerevisiae</named-content> rather than <named-content content-type="genus-species">P. falciparum</named-content> makes the algorithm straightforward and unbiased but also difficult to validate experimentally. Presently, experimental testing of the identified target pairs in <xref ref-type="table" rid="T1">Table 1</xref> is precluded by the lack of inhibitors for most of the proposed targets. However, we think that the presence of targets such as PfPI4K and PfATP4 in <xref ref-type="table" rid="T1">Table 1</xref> validates the algorithm, and we hope that the algorithm will help identify future combinations of antimalarial molecules that potentiate each other.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p><p>We are grateful to Andrew M. Waterhouse for help with Python programming and to Matthias Rottmann for critical reading of the manuscript.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="web"><collab>Medicines for Malaria Venture</collab>. <year>2017</year>
<article-title>MMV drug development portfolio</article-title>. <comment><ext-link ext-link-type="uri" xlink:href="https://www.mmv.org/research-development/mmv-supported-projects">https://www.mmv.org/research-development/mmv-supported-projects</ext-link></comment>.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>NJ</given-names></name></person-group>
<year>2016</year>
<article-title>Can new treatment developments combat resistance in malaria?</article-title>
<source>Expert Opin Pharmacother</source>
<volume>17</volume>:<fpage>1303</fpage>&#x02013;<lpage>1307</lpage>. doi:<pub-id pub-id-type="doi">10.1080/14656566.2016.1187134</pub-id>.<pub-id pub-id-type="pmid">27191998</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <year>2010</year>
<source>Guidelines for the treatment of malaria</source>. <publisher-name>World Health Organization</publisher-name>, <publisher-loc>Geneva, Switzerland</publisher-loc>.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wells</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Hooft van Huijsduijnen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Van Voorhis</surname><given-names>WC</given-names></name></person-group>
<year>2015</year>
<article-title>Malaria medicines: a glass half full?</article-title>
<source>Nat Rev Drug Discov</source>
<volume>14</volume>:<fpage>424</fpage>&#x02013;<lpage>442</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrd4573</pub-id>.<pub-id pub-id-type="pmid">26000721</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kremsner</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>Krishna</surname><given-names>S</given-names></name></person-group>
<year>2004</year>
<article-title>Antimalarial combinations</article-title>. <source>Lancet</source>
<volume>364</volume>:<fpage>285</fpage>&#x02013;<lpage>294</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(04)16680-4</pub-id>.<pub-id pub-id-type="pmid">15262108</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><collab>malERA Consultative Group on Drugs</collab>. <year>2011</year>
<article-title>A research agenda for malaria eradication: drugs</article-title>. <source>PLoS Med</source>
<volume>8</volume>:<elocation-id>e1000402</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.1000402</pub-id>.<pub-id pub-id-type="pmid">21311580</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diagana</surname><given-names>TT</given-names></name></person-group>
<year>2015</year>
<article-title>Supporting malaria elimination with 21st century antimalarial agent drug discovery</article-title>. <source>Drug Discov Today</source>
<volume>20</volume>:<fpage>1265</fpage>&#x02013;<lpage>1270</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.drudis.2015.06.009</pub-id>.<pub-id pub-id-type="pmid">26103616</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conde-Pueyo</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Munteanu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sole</surname><given-names>RV</given-names></name>, <name name-style="western"><surname>Rodriguez-Caso</surname><given-names>C</given-names></name></person-group>
<year>2009</year>
<article-title>Human synthetic lethal inference as potential anti-cancer target gene detection</article-title>. <source>BMC Syst Biol</source>
<volume>3</volume>:<fpage>116</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1752-0509-3-116</pub-id>.<pub-id pub-id-type="pmid">20015360</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giaever</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Ni</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Connelly</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Riles</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Veronneau</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dow</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lucau-Danila</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Andre</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Arkin</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Astromoff</surname><given-names>A</given-names></name>, <name name-style="western"><surname>El-Bakkoury</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bangham</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Benito</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Brachat</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Campanaro</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Curtiss</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Deutschbauer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Entian</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Flaherty</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Foury</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Garfinkel</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Gerstein</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gotte</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Guldener</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Hegemann</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Hempel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Herman</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Jaramillo</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Kotter</surname><given-names>P</given-names></name>, <name name-style="western"><surname>LaBonte</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lamb</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Lan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lussier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Menard</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ooi</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Revuelta</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ross-Macdonald</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Scherens</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Schimmack</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shafer</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Shoemaker</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Sookhai-Mahadeo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Storms</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Strathern</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Valle</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Voet</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Volckaert</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Wilhelmy</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Winzeler</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Youngman</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bussey</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Boeke</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Snyder</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Philippsen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Johnston</surname><given-names>M</given-names></name></person-group>
<year>2002</year>
<article-title>Functional profiling of the <italic>Saccharomyces cerevisiae</italic> genome</article-title>. <source>Nature</source>
<volume>418</volume>:<fpage>387</fpage>&#x02013;<lpage>391</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature00935</pub-id>.<pub-id pub-id-type="pmid">12140549</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>F&#x000fc;gi</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kaiser</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tanner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schneiter</surname><given-names>R</given-names></name>, <name name-style="western"><surname>M&#x000e4;ser</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>XL</given-names></name></person-group>
<year>2015</year>
<article-title>Match-making for posaconazole through systems thinking</article-title>. <source>Trends Parasitol</source>
<volume>31</volume>:<fpage>46</fpage>&#x02013;<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pt.2014.11.004</pub-id>.<pub-id pub-id-type="pmid">25486978</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaelin</surname><given-names>WG</given-names><suffix>Jr</suffix></name></person-group>
<year>2005</year>
<article-title>The concept of synthetic lethality in the context of anticancer therapy</article-title>. <source>Nat Rev Cancer</source>
<volume>5</volume>:<fpage>689</fpage>&#x02013;<lpage>698</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrc1691</pub-id>.<pub-id pub-id-type="pmid">16110319</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roemer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Boone</surname><given-names>C</given-names></name></person-group>
<year>2013</year>
<article-title>Systems-level antimicrobial drug and drug synergy discovery</article-title>. <source>Nat Chem Biol</source>
<volume>9</volume>:<fpage>222</fpage>&#x02013;<lpage>231</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nchembio.1205</pub-id>.<pub-id pub-id-type="pmid">23508188</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adl</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Simpson</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Farmer</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>OR</given-names></name>, <name name-style="western"><surname>Barta</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Bowser</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Brugerolle</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fensome</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Fredericq</surname><given-names>S</given-names></name>, <name name-style="western"><surname>James</surname><given-names>TY</given-names></name>, <name name-style="western"><surname>Karpov</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kugrens</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Krug</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lane</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Lodge</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lynn</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Mann</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>McCourt</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Mendoza</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Moestrup</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Mozley-Standridge</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Nerad</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Shearer</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Smirnov</surname><given-names>AV</given-names></name>, <name name-style="western"><surname>Spiegel</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>MF</given-names></name></person-group>
<year>2005</year>
<article-title>The new higher level classification of eukaryotes with emphasis on the taxonomy of protists</article-title>. <source>J Eukaryot Microbiol</source>
<volume>52</volume>:<fpage>399</fpage>&#x02013;<lpage>451</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1550-7408.2005.00053.x</pub-id>.<pub-id pub-id-type="pmid">16248873</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stark</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Breitkreutz</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Reguly</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Breitkreutz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tyers</surname><given-names>M</given-names></name></person-group>
<year>2006</year>
<article-title>BioGRID: a general repository for interaction datasets</article-title>. <source>Nucleic Acids Res</source>
<volume>34</volume>:<fpage>D535</fpage>&#x02013;<lpage>D539</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkj109</pub-id>.<pub-id pub-id-type="pmid">16381927</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mackey</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Stoeckert</surname><given-names>CJ</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Roos</surname><given-names>DS</given-names></name></person-group>
<year>2006</year>
<article-title>OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups</article-title>. <source>Nucleic Acids Res</source>
<volume>34</volume>:<fpage>D363</fpage>&#x02013;<lpage>D368</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkj123</pub-id>.<pub-id pub-id-type="pmid">16381887</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brunk</surname><given-names>BP</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Harb</surname><given-names>OS</given-names></name>, <name name-style="western"><surname>Iodice</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Shanmugam</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Roos</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Stoeckert</surname><given-names>CJ</given-names><suffix>Jr</suffix></name></person-group>
<year>2011</year>
<article-title>Using OrthoMCL to assign proteins to OrthoMCL-DB groups or to cluster proteomes into new ortholog groups</article-title>. <source>Curr Protoc Bioinformatics</source>
<volume>Chapter 6</volume>:<fpage>Unit 6.12.1</fpage>&#x02013;<lpage>6.12.19</lpage>.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aguero</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Al-Lazikani</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Aslett</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Berriman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Buckner</surname><given-names>FS</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Carmona</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Carruthers</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Crowther</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Doyle</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Hertz-Fowler</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hopkins</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>McAllister</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Nwaka</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Overington</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Pain</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Paolini</surname><given-names>GV</given-names></name>, <name name-style="western"><surname>Pieper</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Ralph</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Riechers</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Roos</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Sali</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shanmugam</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Van Voorhis</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Verlinde</surname><given-names>CL</given-names></name></person-group>
<year>2008</year>
<article-title>Genomic-scale prioritization of drug targets: the TDR Targets database</article-title>. <source>Nat Rev Drug Discov</source>
<volume>7</volume>:<fpage>900</fpage>&#x02013;<lpage>907</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrd2684</pub-id>.<pub-id pub-id-type="pmid">18927591</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aparicio</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Marin-Menendez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Engel</surname><given-names>PC</given-names></name></person-group>
<year>2010</year>
<article-title>Susceptibility of <italic>Plasmodium falciparum</italic> to glutamate dehydrogenase inhibitors: a possible new antimalarial target</article-title>. <source>Mol Biochem Parasitol</source>
<volume>172</volume>:<fpage>152</fpage>&#x02013;<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molbiopara.2010.04.002</pub-id>.<pub-id pub-id-type="pmid">20399810</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ludin</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Woodcroft</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ralph</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Maser</surname><given-names>P</given-names></name></person-group>
<year>2012</year>
<article-title>In silico prediction of antimalarial drug target candidates</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>
<volume>2</volume>:<fpage>191</fpage>&#x02013;<lpage>199</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijpddr.2012.07.002</pub-id>.<pub-id pub-id-type="pmid">24533280</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salcedo-Sora</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Biagini</surname><given-names>GA</given-names></name></person-group>
<year>2012</year>
<article-title>A yeast expression system for functional and pharmacological studies of the malaria parasite Ca<sup>2+</sup>/H<sup>+</sup> antiporter</article-title>. <source>Malar J</source>
<volume>11</volume>:<fpage>254</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1475-2875-11-254</pub-id>.<pub-id pub-id-type="pmid">22853777</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rottmann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McNamara</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yeung</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Seitz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Plouffe</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Dharia</surname><given-names>NV</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Gonzalez-Paez</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Lakshminarayana</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Goh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Suwanarusk</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jegla</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Schmitt</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Beck</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Brun</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nosten</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Renia</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Dartois</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Winzeler</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Diagana</surname><given-names>TT</given-names></name></person-group>
<year>2010</year>
<article-title>Spiroindolones, a potent compound class for the treatment of malaria</article-title>. <source>Science</source>
<volume>329</volume>:<fpage>1175</fpage>&#x02013;<lpage>1180</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1193225</pub-id>.<pub-id pub-id-type="pmid">20813948</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldgof</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Durrant</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Ottilie</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vigil</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Gunawan</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kostylev</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Henderson</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schenken</surname><given-names>J</given-names></name>, <name name-style="western"><surname>LaMonte</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Manary</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Murao</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nachon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stanhope</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Prescott</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McNamara</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Slayman</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Amaro</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Winzeler</surname><given-names>EA</given-names></name></person-group>
<year>2016</year>
<article-title>Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (cipargamin) is a P-type ATPase inhibitor</article-title>. <source>Sci Rep</source>
<volume>6</volume>:<fpage>27806</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep27806</pub-id>.<pub-id pub-id-type="pmid">27291296</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jimenez-Diaz</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Ebert</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Salinas</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pradhan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lehane</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Myrand-Lapierre</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>O'Loughlin</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Shackleford</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Justino de Almeida</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Carrillo</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Dennis</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Diep</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Duffy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Endsley</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Fedewa</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Guiguemde</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Gomez</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Holbrook</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Horst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Matheny</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rodriguez-Alejandre</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sanz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sigal</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Spillman</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Waterson</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Knapp</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shelat</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Avery</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Gamo</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Charman</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Mirsalis</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ferrer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kirk</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Angulo-Barturen</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Kyle</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>DeRisi</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Floyd</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Guy</surname><given-names>RK</given-names></name></person-group>
<year>2014</year>
<article-title>(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of <italic>Plasmodium</italic></article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>111</volume>:<fpage>E5455</fpage>&#x02013;<lpage>E5462</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1414221111</pub-id>.<pub-id pub-id-type="pmid">25453091</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McNamara</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Roland</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Yeung</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Chatterjee</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>McCormack</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Manary</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Zeeman</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Dechering</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Henrich</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Gagaring</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ibanez</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kuhen</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Fischli</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Nagle</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rottmann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Plouffe</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Bursulaya</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Meister</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rameh</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Trappe</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Haasen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Timmerman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sauerwein</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Suwanarusk</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Renia</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nosten</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Tully</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Kocken</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Glynne</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Bodenreider</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Diagana</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Winzeler</surname><given-names>EA</given-names></name></person-group>
<year>2013</year>
<article-title>Targeting <italic>Plasmodium</italic> PI(4)K to eliminate malaria</article-title>. <source>Nature</source>
<volume>504</volume>:<fpage>248</fpage>&#x02013;<lpage>253</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature12782</pub-id>.<pub-id pub-id-type="pmid">24284631</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spillman</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>McNamara</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Yeung</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Winzeler</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Diagana</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Kirk</surname><given-names>K</given-names></name></person-group>
<year>2013</year>
<article-title>Na<sup>+</sup> regulation in the malaria parasite <italic>Plasmodium falciparum</italic> involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials</article-title>. <source>Cell Host Microbe</source>
<volume>13</volume>:<fpage>227</fpage>&#x02013;<lpage>237</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2012.12.006</pub-id>.<pub-id pub-id-type="pmid">23414762</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dembele</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Chavchich</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bonamy</surname><given-names>GMC</given-names></name>, <name name-style="western"><surname>Selva</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Bodenreider</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yeung</surname><given-names>BKS</given-names></name>, <name name-style="western"><surname>Nosten</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Edstein</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Straimer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Diagana</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Bifani</surname><given-names>P</given-names></name></person-group>
<year>2017</year>
<article-title>The <italic>Plasmodium</italic> PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated <italic>Plasmodium falciparum</italic> ring-stage parasites</article-title>. <source>Sci Rep</source>
<volume>7</volume>:<fpage>2325</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-017-02440-6</pub-id>.<pub-id pub-id-type="pmid">28539634</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paquet</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Le Manach</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cabrera</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Younis</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Henrich</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Abraham</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>MCS</given-names></name>, <name name-style="western"><surname>Basak</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ghidelli-Disse</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lafuente-Monasterio</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bantscheff</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ruecker</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Blagborough</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Zakutansky</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Zeeman</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>White</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Shackleford</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Mannila</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Morizzi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Scheurer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Angulo-Barturen</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Ferrer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sanz</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Gamo</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Reader</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Botha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dechering</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Sauerwein</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Tungtaeng</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vanachayangkul</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Burrows</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Witty</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Marsh</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Bodenreider</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rochford</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Solapure</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Jimenez-Diaz</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Wittlin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Charman</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Donini</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Campo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Birkholtz</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Hanson</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Drewes</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kocken</surname><given-names>CHM</given-names></name>, <name name-style="western"><surname>Delves</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Leroy</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Waterson</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Street</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Chibale</surname><given-names>K</given-names></name></person-group>
<year>2017</year>
<article-title>Antimalarial efficacy of MMV390048, an inhibitor of <italic>Plasmodium</italic> phosphatidylinositol 4-kinase</article-title>. <source>Sci Transl Med</source>
<volume>9</volume>:<fpage>eaad9735</fpage>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.aad9735</pub-id>.<pub-id pub-id-type="pmid">28446690</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hain</surname><given-names>AU</given-names></name>, <name name-style="western"><surname>Bartee</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Sullivan</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Levitskaya</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Meyers</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Bosch</surname><given-names>J</given-names></name></person-group>
<year>2014</year>
<article-title>Identification of an Atg8-Atg3 protein-protein interaction inhibitor from the Medicines for Malaria Venture Malaria Box active in blood and liver stage <italic>Plasmodium falciparum</italic> parasites</article-title>. <source>J Med Chem</source>
<volume>57</volume>:<fpage>4521</fpage>&#x02013;<lpage>4531</lpage>. doi:<pub-id pub-id-type="doi">10.1021/jm401675a</pub-id>.<pub-id pub-id-type="pmid">24786226</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Tekwani</surname><given-names>BL</given-names></name></person-group>
<year>2017</year>
<article-title>Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads</article-title>. <source>BMC Pharmacol Toxicol</source>
<volume>18</volume>:<fpage>40</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40360-017-0147-4</pub-id>.<pub-id pub-id-type="pmid">28577368</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LaMonte</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Almaliti</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bibo-Verdugo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>BY</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Antonova-Koch</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Orjuela-Sanchez</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Boyle</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Vigil</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Goldgof</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Gerwick</surname><given-names>L</given-names></name>, <name name-style="western"><surname>O'Donoghue</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Winzeler</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Gerwick</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Ottilie</surname><given-names>S</given-names></name></person-group>
<year>2017</year>
<article-title>Development of a potent inhibitor of the <italic>Plasmodium</italic> proteasome with reduced mammalian toxicity</article-title>. <source>J Med Chem</source>
<volume>60</volume>:<fpage>6721</fpage>&#x02013;<lpage>6732</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.jmedchem.7b00671</pub-id>.<pub-id pub-id-type="pmid">28696697</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>O'Donoghue</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>van der Linden</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Yoo</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Foe</surname><given-names>IT</given-names></name>, <name name-style="western"><surname>Tilley</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Craik</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>da Fonseca</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Bogyo</surname><given-names>M</given-names></name></person-group>
<year>2016</year>
<article-title>Structure- and function-based design of <italic>Plasmodium</italic>-selective proteasome inhibitors</article-title>. <source>Nature</source>
<volume>530</volume>:<fpage>233</fpage>&#x02013;<lpage>236</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature16936</pub-id>.<pub-id pub-id-type="pmid">26863983</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tschan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brouwer</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Werkhoven</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Jonker</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Knittel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aminake</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Pradel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Joanny</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Liskamp</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Mordmuller</surname><given-names>B</given-names></name></person-group>
<year>2013</year>
<article-title>Broad-spectrum antimalarial activity of peptido sulfonyl fluorides, a new class of proteasome inhibitors</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>57</volume>:<fpage>3576</fpage>&#x02013;<lpage>3584</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00742-12</pub-id>.<pub-id pub-id-type="pmid">23689711</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bobenchik</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Witola</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Augagneur</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nic Lochlainn</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Garg</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pachikara</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>YO</given-names></name>, <name name-style="western"><surname>Usmani-Brown</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Adjalley</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Samanta</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Voelker</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Fikrig</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ben Mamoun</surname><given-names>C</given-names></name></person-group>
<year>2013</year>
<article-title><italic>Plasmodium falciparum</italic> phosphoethanolamine methyltransferase is essential for malaria transmission</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>110</volume>:<fpage>18262</fpage>&#x02013;<lpage>18267</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1313965110</pub-id>.<pub-id pub-id-type="pmid">24145416</pub-id></mixed-citation></ref></ref-list></back></article>